Pharmacological Profile of YM087, A Novel Potent Nonpeptide Vasopressin V1A and V2 Receptor Antagonist, in Vitro and in Vivo

Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada, +6

Journal of Pharmacology and Experimental Therapeutics

Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

Naoto Okada, Hitoshi Kawazoe, Kenshi Takechi, +11

Clinical Therapeutics

Cancer ImmunosurveillanceMedicineMelanomaImmunologyMelanoma Treated +7

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

Takeyuki Yatsu, Yuichi Tomura, Atsuo Tahara, +5

European Journal of Pharmacology

NeuropeptidesMedicinePhysiologyNeuropeptide ReceptorNeuropharmacology +4

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte

Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada, +6

Cardiovascular Research

Population Pharmacokinetic Analysis of Vancomycin Using Serum Cystatin C as a Marker of Renal Function

Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, +6

Antimicrobial Agents and Chemotherapy

UrologyRenal FunctionPharmacokinetic ModelingChronic Kidney DiseasePharmacology +11

Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells

Atsuo Tahara, Masayuki Saito, Toru Sugimoto, +8

British Journal of Pharmacology

Pharmacological CharacterizationImmunologyCellular PhysiologyGastrointestinal Peptide HormoneMolecular Pharmacology +21

Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells

Atsuo Tahara, Junko Tsukada, Yuichi Tomura, +6

British Journal of Pharmacology

GynecologyCytoskeletonExperimental PharmacologyCellular PhysiologyPharmacologic Characterization +19

Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

Yuichi Tasaka, Akihiro Tanaka, Daiki Yasunaga, +3

Journal of Pharmaceutical Health Care and Sciences

Estimation of the Initial Dose Setting of Vancomycin Therapy With Use of Cystatin C as a New Marker of Renal Function

Akihiro Tanaka, Katsuya Suemaru, Takashi Otsuka, +8

Therapeutic Drug Monitoring

Vancomycin TherapyTranslational MedicineUrologyRenal FunctionElderly Patients +13

Highly Potent and Orally Active Non-Peptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 4'-[(4,4-Difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-yl)carbonyl]-2-phenylbenzanililde Derivatives.

Yoshiaki Shimada, K. Sakamoto, Takeyuki Yatsu, +1

Chemical and Pharmaceutical Bulletin

Potent AffinityOrganic ChemistryPharmacotherapyPharmaceutical ChemistryV2 Receptors +16